Works in Cancer Chemotherapy & Pharmacology, 2024, Vol 93, Issue 4
Results: 10
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 273, doi. 10.1007/s00280-024-04643-x
- By:
- Publication type:
- Article
Andrographolide inhibits Burkitt's lymphoma by binding JUN and CASP3 proteins.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 381, doi. 10.1007/s00280-023-04626-4
- By:
- Publication type:
- Article
Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 365, doi. 10.1007/s00280-023-04625-5
- By:
- Publication type:
- Article
Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 319, doi. 10.1007/s00280-023-04619-3
- By:
- Publication type:
- Article
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 353, doi. 10.1007/s00280-023-04615-7
- By:
- Publication type:
- Article
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 329, doi. 10.1007/s00280-023-04613-9
- By:
- Publication type:
- Article
Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 307, doi. 10.1007/s00280-023-04612-w
- By:
- Publication type:
- Article
CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 295, doi. 10.1007/s00280-023-04610-y
- By:
- Publication type:
- Article
Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 341, doi. 10.1007/s00280-023-04605-9
- By:
- Publication type:
- Article
Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 393, doi. 10.1007/s00280-023-04597-6
- By:
- Publication type:
- Article